TriNetX moves to new headquarters in Cambridge, MA after outgrowing space

By Melissa Fassbender contact

- Last updated on GMT

Related tags: Contract research organizations, Clinical trial

(Image: TriNetx)
(Image: TriNetx)
TriNetX has completed a yearlong project to expand its space from 8,200 to a 20,000 square feet in response to industry demand for its clinical trial services.

TriNetX is a health research network for healthcare organizations, biopharmaceutical companies, and contract research organizations (CROs), such as Icon, which uses the company’s technology platform​ to connect with electronic medical records (EMRs) across the globe.

The cloud-based, health research platform enables TriNetX customers to analyze patient populations across multiple data points.

According to the company, the new, expanded headquarters in Cambridge, MA will feature a Network Operations Center (NOC), which will provide real-time visibility into the operating status of TriNetX devices at organizations across the world.

This was an investment in our employees, both current and future​,” Gadi Lachman, CEO of TriNetX told Outsourcing-Pharma.com.

The company has grown from 20 to 75 and outgrew its existing space.

We want the space to be an energizing place to work in, the location to provide us with a competitive advantage in our recruitment of top talent, and the technology to be state-of-art so that we can work in an efficient manner​,” added Lachman.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars